CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pramana, an AI-enabled health technology company, will introduce Digital Pathology 2.0 – the new standard in whole slide imaging – and showcase its Digital Pathology ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--OptraSCAN announces today it has launched its 120-slide Whole Slide Imaging scanner as part of its On-Demand Subscription model to affordably automate Digital ...

Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services BURLINGTON, N.C., Sept. 30, 2025 /PRNewswire ...

The utilization of digital microscopes to perform whole-slide imaging (WSI) provides multiple advantages to pathology, bioscience, and healthcare research. However, the ubiquity and simplicity of ...

SANTA CLARA, Calif., January 23, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital ...

Grand Blanc, Mich.-based McLaren Health Care fully transitioned to digital pathology services July 1. The system’s central core laboratory and 12 hospital-based laboratories now scan glass pathology ...

Digital pathology is the management of data formed from digital images of glass slides. There are four steps involved in the process of digital imaging: The acquisition of the image. Image storage and ...

Baylor College of Medicine has teamed with Leica Biosystems, a cancer diagnostics company and global leader in workflow solutions, to launch Baylor's worldwide pathology services. "Through creative ...

A digital pathology collaboration between Microsoft, the University of Washington and Providence health network aims to overcome a few of the obstacles to fully implementing artificial intelligence in ...

Pathology is the study of disease — its causes, effects and very nature. Studying disease is a very broad discipline that involves a wide range of scientists and medical professionals. Pathologists, ...

The vast majority of drug compounds fail in the preclinical stage, and pharmaceutical and biotech companies are continuously looking for preclinical process improvements to better manage costs and ...